Dr. Pue has over 30 years of international experience in the healthcare industry in established and evolving pharmaceutical and medical technology companies and has worked across all aspects of the drug life-cycle from discovery to commercialization operating in permanent, interim management and consultancy roles.
Starting out in drug metabolism and pharmacokinetics, Dr. Pue has worked in most areas of nonclinical and clinical drug development and registration. He has managed the nonclinical development through first-in-man and Proof-of-Concept clinical trials and subsequent Phase II / III clinical development of several new chemical entities and a medical device.
Dr. Pue has facilitated and led key long-term programme alliances with public and private companies in the USA, Europe and Asia, including new business development, due diligence and licensing deals. He has established effective working relationships with external commercial partners to achieve the successful European and North American launches of frovatriptan (for the acute treatment of migraine) and with internal organizations for the commercialization of apomorphine injection (Parkinson’s Disease).
Go to Dr. Pue’s profile at LinkedIn.